← All candidates
14 insider filings on record.
21 filings on record.
CAPRCAPRICOR THERAPEUTICS, INC.
NasdaqGS · Healthcare · $512.20M
$8.81
+5.26% · Sep 14
14 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 6 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 2×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what CAPR ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$512.20M
Float
45.5M
78% public
Short % float
Pro
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
4 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
9 more transactions on Pro →Context
Wall St
$27.00 avg target
+206.5% vs today · 5 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
1 of 3 quarters beat
Q2 '26−$0.70 act−$0.12
Q4 '25−$0.62 act−$0.07
Q3 '25−$0.54 act+$0.00
Coverage
CAPR Stock Skyrockets 144% in a Month: What Is Driving the Rally?Zacks · 1w agoCould New Long-Term Data Support Capricor’s Duchenne Therapy?Insider Monkey · 1w agoCapricor Therapeutics shares rise 2.5% following August FDA updateInvestorsHub · 2w agoWhy Is CAPR Stock Rising Today? Piper Sandler Says Risk-Reward Favors Owning Stock Into FDA DecisionStocktwits · 2w ago
The file stays open
21 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice